Mallory hyaline is seen in which of the following conditions?
Which of the following is not a typical feature of autoimmune hepatitis?
Which virus causes hepatocellular carcinoma?
Rokitansky-Aschoff sinuses are seen in which of the following conditions?
In anoxia of the liver, in which region is necrosis typically seen?
Which of the following histological features is most characteristic of acute viral hepatitis?
Nodular regenerating hyperplasia is associated with which of the following?
Alagille syndrome is characterized by which of the following findings?
A 40-year-old male with a history of chronic alcoholism is diagnosed with cirrhosis and presents with a lump in the right lobe of the liver. His serum AFP level is normal. What is the most probable diagnosis?
Increased lipolysis of fat stores, which can result from starvation, diabetes mellitus, or corticosteroid use, is most likely to cause steatosis (fatty liver) through which one of the listed mechanisms?
Explanation: **Explanation:** **Mallory-Denk bodies (Mallory Hyaline)** are eosinophilic, rope-like intracytoplasmic inclusions found within hepatocytes. They represent an accumulation of damaged intermediate filaments, specifically **Cytokeratin 8 and 18**, which have been ubiquitinated and cross-linked. **Why "All of the above" is correct:** While classically associated with **Alcoholic Liver Disease** (where they are most prominent), Mallory hyaline is not pathognomonic for it [1]. It is a non-specific marker of hepatocyte injury and can be seen in several chronic liver conditions: * **Alcoholic Liver Disease (Option A):** The most common association, especially in alcoholic hepatitis [1]. * **Hepatocellular Carcinoma (Option B):** Can be found within the malignant hepatocytes. * **Wilson’s Disease (Option C):** Often seen during the chronic inflammatory phase. * **Other conditions:** Non-alcoholic steatohepatitis (NASH), Primary Biliary Cholangitis (PBC), Indian Childhood Cirrhosis, and Alpha-1 antitrypsin deficiency [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Composition:** Primarily Cytokeratin 8 and 18 (Intermediate filaments). * **Staining:** They appear bright pink/eosinophilic on H&E stain. They can be highlighted using **Ubiquitin** or **p62** immunohistochemical stains. * **Key Distinction:** Do not confuse Mallory bodies with **Councilman bodies** (apoptotic hepatocytes seen in Yellow Fever and Viral Hepatitis) or **Negri bodies** (seen in Rabies). * **Mnemonic:** "Mallory is a **W**eird **A**nd **I**nsecure **N**eighbor" (**W**ilson’s, **A**lcoholic hepatitis, **I**ndian childhood cirrhosis, **N**ASH). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-390. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854.
Explanation: **Explanation:** The correct answer is **D. Ground glass hepatocytes**. This is a characteristic histological feature of **Chronic Hepatitis B infection**, caused by the massive accumulation of Hepatitis B surface antigen (HBsAg) within the smooth endoplasmic reticulum [1]. On H&E stain, these cells appear as finely granular, eosinophilic cytoplasm with a distinct clear halo. **Why the other options are incorrect (Features of Autoimmune Hepatitis):** Autoimmune Hepatitis (AIH) is characterized by a "plasma cell-rich" inflammatory infiltrate. Its hallmark histological features include: * **Interface Hepatitis (Option A):** This is the most characteristic feature, where dense inflammatory infiltrates (lymphocytes and plasma cells) spill over from the portal tracts into the adjacent periportal parenchyma, causing necrosis of limiting plate hepatocytes [1]. * **Emperipolesis (Option B):** This refers to the active penetration of one cell into another (typically a CD8+ T-cell or plasma cell entering a hepatocyte), where the engulfed cell remains viable [1]. * **Hepatic Rosette Formation (Option C):** In response to injury, regenerating hepatocytes arrange themselves in circular clusters or "pseudorosettes" [1]. **NEET-PG High-Yield Pearls:** * **Serology:** Type 1 AIH is associated with **ANA** and **Anti-Smooth Muscle Antibodies (ASMA)**. Type 2 AIH (more common in children) is associated with **Anti-LKM1** antibodies [1]. * **Hypergammaglobulinemia:** A key diagnostic clue is a disproportionate rise in serum IgG levels [1]. * **Staining:** Ground glass hepatocytes (HBV) can be specifically highlighted using **Orcein** or **Victoria Blue** stains. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-846.
Explanation: **Explanation:** **Hepatitis B Virus (HBV)** is a well-established oncogenic virus and a leading cause of **Hepatocellular Carcinoma (HCC)** worldwide [1]. Unlike Hepatitis C, HBV is a DNA virus that can integrate its genome into the host hepatocyte DNA [2]. This integration causes genomic instability and activates endogenous proto-oncogenes [2]. Furthermore, the **HBx protein** produced by the virus disrupts cell cycle control by binding to and inactivating the tumor suppressor protein **p53**, directly promoting carcinogenesis even in the absence of cirrhosis [2], [3]. **Analysis of Incorrect Options:** * **Arboviruses (Option A):** These are viruses transmitted by arthropod vectors (e.g., Dengue, Zika, Yellow Fever). While Yellow Fever affects the liver (causing Councilman bodies), it does not cause chronic infection or malignancy. * **Herpes Simplex Virus (Option B):** HSV can cause fulminant hepatitis in immunocompromised patients or pregnant women (characterized by "punched-out" necrosis), but it is not associated with chronic liver disease or HCC. * **Hepatitis A Virus (Option C):** HAV is transmitted via the fecal-oral route and causes acute hepatitis only [4]. It never progresses to a chronic state, carrier state, or malignancy [4]. **High-Yield Clinical Pearls for NEET-PG:** * **HBV vs. HCV:** HBV is the most common cause of HCC globally, but HCV is a major contributor in Western nations [1]. HBV can cause HCC **without** prior cirrhosis, whereas HCV-induced HCC almost always occurs in a cirrhotic liver [1]. * **Tumor Marker:** Alpha-fetoprotein (AFP) is the classic screening marker for HCC. * **Aflatoxin B1:** Produced by *Aspergillus flavus*, this dietary toxin acts synergistically with HBV to increase HCC risk by causing a specific mutation in the **p53 gene (codon 249)** [1]. * **Morphology:** Look for "Ground-glass hepatocytes" (HBsAg accumulation) in chronic HBV infection [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 336-337. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 838-840. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 842.
Explanation: **Explanation:** **Rokitansky-Aschoff (R-A) sinuses** are the hallmark histopathological feature of **Chronic Cholecystitis** [1]. ### 1. Why Chronic Cholecystitis is Correct? Chronic cholecystitis is characterized by persistent inflammation and fibrosis of the gallbladder wall, usually due to gallstones. The underlying mechanism involves **increased intraluminal pressure**, which causes the mucosal epithelium to herniate through the muscularis propria. These deep outpocketings of the mucosa into the muscular layer are termed Rokitansky-Aschoff sinuses [1]. While they are not inherently neoplastic, they are diagnostic of chronic inflammatory changes. ### 2. Analysis of Incorrect Options: * **A. Acute Cholecystitis:** This is characterized by neutrophil infiltration, edema, and mucosal ulceration. While R-A sinuses may be present if there is "acute-on-chronic" inflammation, they are not a defining feature of primary acute cholecystitis. * **C. Xanthogranulomatous Cholecystitis:** This is a rare variant of chronic cholecystitis characterized by the presence of **foamy macrophages (lipid-laden)** and giant cells. While R-A sinuses may be seen, the presence of xanthoma cells is the distinguishing feature. * **D. Gallbladder Carcinoma:** This involves malignant epithelial proliferation with cellular atypia and invasion. While R-A sinuses can sometimes be mistaken for invasive carcinoma (pseudoinvasion), they are benign structures. ### 3. NEET-PG High-Yield Pearls: * **Definition:** R-A sinuses = Mucosal herniations through the muscularis propria. * **Luschka’s Ducts:** Do not confuse R-A sinuses with Luschka’s ducts. Luschka’s ducts are accessory bile ducts located in the gallbladder wall (usually on the hepatic surface) and are not related to inflammation. * **Porcelain Gallbladder:** A late complication of chronic cholecystitis where the wall becomes calcified; it carries an increased risk of gallbladder carcinoma. * **Strawberry Gallbladder:** Refers to **Cholesterolosis**, which involves focal accumulations of cholesterol-laden macrophages in the lamina propria (not R-A sinuses). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 884-886.
Explanation: ### Explanation **1. Why Centrilobular is Correct:** The liver is organized into functional units called **Rappaport acini**, which are divided into three zones based on their proximity to the blood supply [2]. * **Zone 1 (Periportal):** Receives the most oxygenated blood. * **Zone 3 (Centrilobular/Perivenular):** Located furthest from the arterial supply, surrounding the central vein [2]. In states of **anoxia, hypoxia, or hypoperfusion** (e.g., congestive heart failure or shock), Zone 3 receives the least amount of oxygen [3]. Consequently, it is the first area to undergo ischemic necrosis. This pattern is classically referred to as **Centrilobular Necrosis** [1]. **2. Why the Other Options are Incorrect:** * **B. Around the periphery:** This refers to Zone 1 (Periportal). This area is the *last* to be affected by hypoxia but the *first* to be affected by ingested toxins (e.g., phosphorus) or viral hepatitis [2]. * **C. Around the central vein:** While technically the same anatomical location as centrilobular, "Centrilobular" is the standard pathological term used to describe this zone-specific necrosis in the context of the acinus. * **D. Around the bile duct:** Bile duct damage is characteristic of primary biliary cholangitis or obstructive jaundice, not systemic anoxia. **3. NEET-PG High-Yield Pearls:** * **Nutmeg Liver:** Chronic passive congestion (often from right-sided heart failure) leads to centrilobular congestion and necrosis, creating a mottled appearance resembling a nutmeg [1]. * **Zone 2 (Mid-zonal):** Necrosis here is rare but classically associated with **Yellow Fever**. * **Acetaminophen (Paracetamol) Toxicity:** Also causes **Zone 3 necrosis** because this zone has the highest concentration of Cytochrome P450 enzymes, which convert the drug into its toxic metabolite (NAPQI). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 870-872. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 828. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 150-151.
Explanation: ### Explanation **Correct Option: D. Necrosis around central veins** In **acute viral hepatitis**, the primary site of injury is the liver parenchyma [1], [2]. The characteristic histological hallmark is **spotty necrosis** (or lobular hepatitis), which is most prominent in **Zone 3 (centrilobular area)** around the central veins [1]. This occurs because hepatocytes in Zone 3 are furthest from the arterial blood supply and are most susceptible to metabolic and inflammatory stress. Morphologically, this is seen as: * **Ballooning degeneration:** Swelling of hepatocytes. * **Acidophil bodies (Councilman bodies):** Shrunken, eosinophilic, apoptotic hepatocytes [2]. --- ### Why the other options are incorrect: * **A. Mononuclear cell infiltration:** While present in acute hepatitis, it is a non-specific finding seen in almost all inflammatory liver conditions (including chronic hepatitis and drug-induced injury) [3]. It is not the *most* characteristic diagnostic feature. * **B. Scarring (Fibrosis):** This is a hallmark of **chronic** liver disease and cirrhosis. Acute viral hepatitis typically resolves without scarring unless it progresses to submassive or massive necrosis [1]. * **C. Interface hepatitis:** Formerly known as "piecemeal necrosis," this refers to inflammation and erosion of the limiting plate (the boundary between the portal tract and parenchyma). This is the classic histological hallmark of **chronic hepatitis**, not acute [3]. --- ### NEET-PG High-Yield Pearls: * **Councilman Bodies:** These are apoptotic hepatocytes characteristic of viral hepatitis (and Yellow Fever) [2]. * **Ground Glass Hepatocytes:** Characteristic of **Chronic Hepatitis B** (due to HBsAg accumulation in the ER) [3]. * **Sanded Nuclei:** Seen in **Hepatitis B** (due to HBcAg). * **Lymphoid Aggregates & Steatosis:** Often suggestive of **Hepatitis C** infection [3]. * **Bridging Necrosis:** Necrosis connecting portal-to-portal or portal-to-central areas; it indicates a more severe clinical course [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, p. 832. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 386-387. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 843-844.
Explanation: **Explanation:** **Nodular Regenerative Hyperplasia (NRH)** is a condition characterized by the diffuse transformation of liver parenchyma into small, regenerative nodules without significant fibrosis. The underlying pathophysiology involves **obliterative portal venopathy**, leading to an uneven blood supply where some areas atrophy while others undergo compensatory hyperplasia. **Why Drug Toxicity is Correct:** NRH is strongly associated with various systemic conditions and exposures that affect the hepatic microvasculature. **Drug toxicity**, particularly from chemotherapeutic agents (e.g., **Azathioprine**, 6-thioguanine, Oxaliplatin) and immunosuppressants, is a well-documented cause [1]. Other major associations include autoimmune diseases (Rheumatoid Arthritis, Felty syndrome) and myeloproliferative disorders. **Analysis of Incorrect Options:** * **A. Budd-Chiari Syndrome:** This involves obstruction of hepatic venous outflow [2]. While it causes congestion and "nutmeg liver," it typically leads to centrilobular necrosis and fibrosis rather than the diffuse non-fibrotic nodularity seen in NRH [2]. * **B. Alcohol Abuse:** Chronic alcohol consumption leads to steatosis, alcoholic hepatitis, and eventually **Cirrhosis** [1]. Unlike NRH, cirrhosis is defined by the presence of extensive bridging fibrosis. * **C. Hepatitis B Infection:** This is a primary cause of post-necrotic cirrhosis. NRH occurs in the *absence* of significant inflammation or viral-induced scarring. **NEET-PG High-Yield Pearls:** * **Key Histology:** Nodules are present, but **Reticulin stain** will show absence of fibrosis (distinguishing it from cirrhosis). * **Clinical Presentation:** Often presents as **non-cirrhotic portal hypertension** (splenomegaly, varices) in a patient with normal liver function tests. * **Association:** Always look for a history of **organ transplantation** or **HIV treatment** (Highly Active Antiretroviral Therapy) in clinical vignettes. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 846-847. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 869-870.
Explanation: **Explanation:** **Alagille Syndrome** is an autosomal dominant multisystem disorder, most commonly caused by mutations in the **JAG1 gene** (Notch signaling pathway). The hallmark pathological feature is **Bile Duct Paucity**, defined as a reduced ratio of interlobular bile ducts to portal tracts (typically <0.4). * **Why Option A is Correct:** In Alagille syndrome, there is a failure in the development of the intrahepatic biliary tree. Histologically, this manifests as a significant scarcity of bile ducts within the portal triads, leading to chronic cholestasis and jaundice in neonates or young children. * **Why Options B, C, and D are Incorrect:** * **IHBR Dilation:** This is characteristic of obstructive conditions (like biliary atresia or stones) or Caroli disease, not a developmental lack of ducts. * **PBC:** This is an autoimmune destruction of small bile ducts typically seen in middle-aged women, characterized by "florid duct lesions" and anti-mitochondrial antibodies (AMA). * **PSC:** This involves "onion-skin" fibrosis of the bile ducts and is strongly associated with Ulcerative Colitis; it affects both intra- and extrahepatic ducts. **High-Yield Clinical Pearls for NEET-PG:** * **Genetic Mutation:** *JAG1* (90%) or *NOTCH2* genes. * **Clinical Pentad:** 1. **Liver:** Cholestasis due to bile duct paucity. 2. **Heart:** Peripheral pulmonary artery stenosis (most common). 3. **Eyes:** Posterior embryotoxon (anterior chamber defect). 4. **Skeletal:** "Butterfly vertebrae" (clefting of vertebral bodies). 5. **Facies:** Characteristic "triangular facies" (prominent forehead, deep-set eyes, pointed chin). * **Diagnosis:** Often suspected in an infant with neonatal jaundice and a heart murmur.
Explanation: **Explanation:** **1. Why Hepatocellular Carcinoma (HCC) is correct:** In a patient with **chronic alcoholism and cirrhosis**, the development of a new liver mass is **HCC until proven otherwise** [3]. Cirrhosis is the strongest predisposing factor for HCC, present in 80-90% of cases [2]. A crucial high-yield point for NEET-PG is that **Serum Alpha-Fetoprotein (AFP) is normal in approximately 30-40% of HCC cases**. A normal AFP level does not exclude the diagnosis, especially in early or well-differentiated HCC [1]. **2. Why other options are incorrect:** * **Fibrohyperplasia (Focal Nodular Hyperplasia):** This is a benign, non-neoplastic response to vascular malformation, typically seen in young women. It is not associated with cirrhosis or alcoholism. * **Metastases:** While metastases are the most common tumors of the liver overall, in the specific setting of **underlying cirrhosis**, primary HCC is statistically more likely than metastatic disease (as cirrhosis is somewhat "protective" against certain metastases due to altered vascularity). * **Hepatocellular Adenoma:** This is a benign tumor strongly associated with **oral contraceptive pill (OCP) use** in women or anabolic steroid use. It rarely occurs in the background of alcoholic cirrhosis. **Clinical Pearls for NEET-PG:** * **Most common site of metastasis for HCC:** Lungs (via hematogenous spread). * **Radiological Hallmark:** "Wash-in" (arterial phase enhancement) and "Wash-out" (venous phase) on Triphasic CT. * **Fibrolamellar Variant:** A subtype of HCC seen in young adults, **not** associated with cirrhosis, and typically has a **normal AFP**. * **Screening:** Patients with cirrhosis should undergo USG and AFP levels every 6 months [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389.
Explanation: Steatosis (fatty change) occurs when there is an imbalance between the delivery/synthesis of lipids and their utilization/export. In the context of **starvation, diabetes mellitus, and corticosteroid use**, the body enters a catabolic state where peripheral adipose tissue undergoes **increased lipolysis**. This releases a massive amount of **Free Fatty Acids (FFAs)** into the bloodstream, which are then delivered to the liver [1]. Once in the hepatocytes, these FFAs are esterified into **triglycerides**, overwhelming the liver's capacity to export them as VLDL, thus leading to lipid accumulation [2]. **Analysis of Options:** * **Option A (Incorrect):** The liver does not "excrete" free fatty acids directly; they are either oxidized for energy or converted into triglycerides and exported as Very Low-Density Lipoproteins (VLDL). * **Option B (Incorrect):** A high NADH/NAD ratio is the primary mechanism for **Alcoholic Liver Disease**. While it does shift metabolism toward lipid synthesis, it is not the primary mechanism driven by peripheral lipolysis in starvation or diabetes. * **Option D (Incorrect):** Inhibition of apoprotein synthesis (e.g., in Protein-Energy Malnutrition/Kwashiorkor or CCl4 poisoning) prevents the formation of VLDL, leading to triglyceride accumulation, not phospholipid accumulation. **High-Yield NEET-PG Pearls:** * **Most common cause of Steatosis (Global):** Alcohol abuse and Obesity/Metabolic Syndrome (NAFLD). * **Morphology:** Macrovesicular steatosis is common; the nucleus is displaced to the periphery [3]. * **Microvesicular steatosis:** Seen in Reye’s syndrome, Fatty liver of pregnancy, and Valproate toxicity (Emergency conditions). * **Stains for Fat:** Sudan IV or Oil Red O (requires **frozen sections**, as routine processing with alcohol/xylene dissolves fat). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1114-1115. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 851-852. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854.
Jaundice and Cholestasis
Practice Questions
Viral Hepatitis
Practice Questions
Alcoholic and Non-alcoholic Fatty Liver Disease
Practice Questions
Drug and Toxin Induced Liver Injury
Practice Questions
Cirrhosis and Its Complications
Practice Questions
Metabolic Liver Diseases
Practice Questions
Liver Tumors
Practice Questions
Gallbladder and Biliary Tract Diseases
Practice Questions
Congenital Liver Diseases
Practice Questions
Liver Transplantation Pathology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free